Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,687 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study.
Kawamoto T, Shikama N, Imano N, Kubota H, Kosugi T, Sekii S, Harada H, Yamada K, Naoi Y, Miyazawa K, Hirano Y, Wada Y, Tonari A, Saito T, Uchida N, Araki N, Nakamura N. Kawamoto T, et al. Among authors: harada h. Breast Cancer. 2023 Mar;30(2):282-292. doi: 10.1007/s12282-022-01422-5. Epub 2022 Dec 17. Breast Cancer. 2023. PMID: 36528759
Patterns of practice in palliative radiotherapy for painful bone metastases: a survey in Japan.
Nakamura N, Shikama N, Wada H, Harada H, Nozaki M, Nagakura H, Tago M, Oguchi M, Uchida N; Japanese Radiation Oncology Study Group Working Subgroup of Palliative Radiotherapy. Nakamura N, et al. Among authors: harada h. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e117-20. doi: 10.1016/j.ijrobp.2011.11.075. Epub 2012 Feb 28. Int J Radiat Oncol Biol Phys. 2012. PMID: 22381902
Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
Ohnishi K, Nakamura N, Harada H, Tokumaru S, Wada H, Arimura T, Iwata H, Sato Y, Sekino Y, Tamamura H, Mizoe JE, Ogino T, Ishikawa H, Kikuchi Y, Okimoto T, Murayama S, Akimoto T, Sakurai H. Ohnishi K, et al. Among authors: harada h. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):82-89. doi: 10.1016/j.ijrobp.2019.09.013. Epub 2019 Oct 1. Int J Radiat Oncol Biol Phys. 2020. PMID: 31580927 Free article.
Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group.
Kubota H, Nakamura N, Shikama N, Tonari A, Wada H, Harada H, Nagakura H, Heianna J, Ito K, Nozaki M, Tago M, Fushiki M, Uchida N, Araki N, Sekii S, Kosugi T, Takahashi T, Kawamoto T, Saito T, Yamada K. Kubota H, et al. Among authors: harada h. J Radiat Res. 2021 Mar 10;62(2):356-363. doi: 10.1093/jrr/rraa133. J Radiat Res. 2021. PMID: 33454759 Free PMC article.
Palliative brachytherapy and external beam radiotherapy for dysphagia from esophageal cancer: a nationwide survey in Japan.
Kawamoto T, Nakamura N, Saito T, Tonari A, Wada H, Harada H, Kubota H, Nagakura H, Heianna J, Miyazawa K, Yamada K, Tago M, Fushiki M, Nozaki M, Uchida N, Araki N, Sekii S, Kosugi T, Takahashi T, Shikama N. Kawamoto T, et al. Among authors: harada h. Jpn J Clin Oncol. 2021 May 28;51(6):950-955. doi: 10.1093/jjco/hyab015. Jpn J Clin Oncol. 2021. PMID: 33624768
Clinical impact of tumour burden on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy in non-small-cell lung cancer.
Miyawaki T, Kenmotsu H, Doshita K, Kodama H, Nishioka N, Iida Y, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Endo M, Takahashi K, Takahashi T. Miyawaki T, et al. Among authors: harada h. Cancer Med. 2023 Jan;12(2):1451-1460. doi: 10.1002/cam4.5035. Epub 2022 Jul 18. Cancer Med. 2023. PMID: 35848053 Free PMC article.
2,687 results